Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups

Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan

(2018) Chang-Hua Chen et al.   MEDICINE

Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations

(2017) Yang Wang et al.   Human Vaccines & Immunotherapeutics

Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China

(2016) Daijun Zhao et al.   VACCINE

Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990–2013

(2016) Elaine R. Miller et al.   VACCINE

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

(2016) Hannah Kraicer-Melamed et al.   VACCINE

Factors associated with pneumococcal vaccination among an urban elderly population in China

(2014) Shijun Liu et al.   Human Vaccines & Immunotherapeutics

Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project

(2010) Hope L. Johnson et al.   PLOS MEDICINE

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions

(2009) Isla Ogilvie et al.   VACCINE